Adenocarcinoma of the lung biopsy: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Adenocarcinoma of the lung}} {{CMG}}; {{AE}} {{SC}} ==Overview== ==References== {{reflist|2}} {{WikiDoc Help Menu}} {{WikiDoc Sources}} Category:Disease C...")
 
No edit summary
 
(11 intermediate revisions by 2 users not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{SC}}
{{CMG}}; {{AE}} {{SC}}
==Overview==
==Overview==
Biopsy is the diagnostic study of choice for adenocarcinoma of the lung. On microscopic [[Histopathology|histopathological]] analysis, nuclear atypia, eccentrically placed [[Cell nucleus|nuclei]], abundant [[cytoplasm]], and conspicuous [[Nucleolus|nucleoli]] are characteristic findings of adenocarcinoma of the lung. Atypical adenomatous hyperplasia (AAH) is the precursor of peripheral adenocarcinomas. It consists of well-demarcated [[Columnar epithelia|columnar]] or [[Cuboidal epithelia|cuboidal]] cells with varying degrees of cytologic [[atypia]], hyperchromasia, [[pleomorphism]] and prominent [[nucleoli]].


==Biopsy==
* [[Biopsy]] is helpful in the diagnosis of adenocarcinoma of the lung.
** [[Fine needle aspiration]] (FNA)<ref name="cancada">Lung cancer. Canadian Cancer Society 2015.http://www.cancer.ca/en/cancer-information/cancer-type/lung/diagnosis/?region=ab#Endoscopy</ref>:
*** [[FNA|CT guided FNA]] uses a small amount of tissue from a suspected lung [[tumor]] or from a [[lymph node]] in the chest.
*** [[Needle aspiration biopsy|FNA]] may also be obtained during [[bronchoscopy]], along with [[Ultrasound|endobronchial ultrasound]], to take samples of [[Lymph node|lymph nodes]] around the [[Vertebrate trachea|trachea]] and [[Bronchus|bronchi]].
:* [[Thoracentesis]]
:** [[Thoracentesis]] may be done to remove fluid from around the [[Lung|lungs]] to see if it contains [[Cancer|cancer cells]]. 
:* On microscopic [[Histopathology|histopathological]] analysis, nuclear atypia, eccentrically placed [[Cell nucleus|nuclei]], abundant [[cytoplasm]], and conspicuous [[Nucleolus|nucleoli]] are characteristic findings of adenocarcinoma of the lung. 
:* Atypical adenomatous hyperplasia (AAH): is the precursor of [[Adenocarcinomas|peripheral adenocarcinomas]].  It consists of well demarcated [[Columnar epithelia|columnar]] or [[Cuboidal epithelia|cuboidal]] cells with the following features:<ref>{{cite book | last = Kumar | first = Vinay | title = Robbins basic pathology | publisher = Saunders/Elsevier | location = Philadelphia, PA | year = 2007 | isbn = 1416029737 }}</ref><ref>{{cite book | last = Stewart | first = Bernard | title = World cancer report 2014 | publisher = International Agency for Research on Cancer,Distributed by WHO Press, World Health Organization | location = Lyon, France Geneva, Switzerland | year = 2014 | isbn = 9283204298 }}</ref>
:** Varying degrees of cytologic [[atypia]] 
:** Hyperchromasia 
:** [[Pleomorphism]] 
:** Prominent [[nucleoli]] 
:* As [[adenocarcinoma]] is a derivative of [[mucus]] producing glands in the lungs, it tends to stain [[mucin]] positive. 
:* Based on differentiation, the [[tumor]] may be:
:** Well differentiated (low grade): Normal appearance 
:** Poorly differentiated (high grade): Abnormal [[Gland|glandular]] appearance with a positive mucin stain
=== Histopathological subtype: ===
* [[Biopsy]] specimen may show different [[Histology|histological]] subtypes.
* For information on [[Histology|histological subtypes]] of adenocarcinoma of the lung and their [[Histopathology|histopathological]] feature, [[Adenocarcinoma of the lung pathophysiology#Histological Subtypes|'''click here''']].
:
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Latest revision as of 18:46, 20 February 2019

Adenocarcinoma of the Lung Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adenocarcinoma of the Lung from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Intervention

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adenocarcinoma of the lung biopsy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adenocarcinoma of the lung biopsy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adenocarcinoma of the lung biopsy

CDC on Adenocarcinoma of the lung biopsy

Adenocarcinoma of the lung biopsy in the news

Blogs on Adenocarcinoma of the lung biopsy

Directions to Hospitals Treating Adenocarcinoma of the lung

Risk calculators and risk factors for Adenocarcinoma of the lung biopsy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Biopsy is the diagnostic study of choice for adenocarcinoma of the lung. On microscopic histopathological analysis, nuclear atypia, eccentrically placed nuclei, abundant cytoplasm, and conspicuous nucleoli are characteristic findings of adenocarcinoma of the lung. Atypical adenomatous hyperplasia (AAH) is the precursor of peripheral adenocarcinomas. It consists of well-demarcated columnar or cuboidal cells with varying degrees of cytologic atypia, hyperchromasia, pleomorphism and prominent nucleoli.

Biopsy

Histopathological subtype:

References

  1. Lung cancer. Canadian Cancer Society 2015.http://www.cancer.ca/en/cancer-information/cancer-type/lung/diagnosis/?region=ab#Endoscopy
  2. Kumar, Vinay (2007). Robbins basic pathology. Philadelphia, PA: Saunders/Elsevier. ISBN 1416029737.
  3. Stewart, Bernard (2014). World cancer report 2014. Lyon, France Geneva, Switzerland: International Agency for Research on Cancer,Distributed by WHO Press, World Health Organization. ISBN 9283204298.


Template:WikiDoc Sources